Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
C. Light Technologies is a developer of a retinal eye-tracking platform used to improve the monitoring of neurodegenerative diseases.
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.
Autonomous Healthcare is a medical technology company pioneering the use of automation in clinical care workflows
Venova is creating a unique method of birth control for women that is long-acting, extremely effective, and free of adverse effects.
Atantares is a company that makes smart chips that empower medical technology.
Gel4Med is the Smart Materials Company paving the way to the future of regenerative medicine.
Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.
Bright Uro is an early-stage medical technology company.
Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.
Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.
Spike Neuro is a biotechnology company that offers neural research device performance using innovative materials and engineering design.
eXoZymes specializes in enzyme design and the development of cell-free enzymatic pathways.
DIMERx operates as a biopharmaceutical company.
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
BiaCure Therapies an emerging innovator in non-invasive medical technology,
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
InformAI delivers AI-enabled clinical solution focused on oncology and diagnostic imaging to improve patient outcomes.
Hepatx is developing regenerative medicine solutions.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Micro-Leads Medical is a medical technology company dedicated to developing innovative therapies that address the neuromodulation.
PhagePro is an early-stage biotechnology therapeutics company.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Therapeutics. The firm invests across 19 different industry categories.
Among tracked funding rounds, Therini Bio received $39.0M in a Series A round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include C. Light Technologies, Myosin Therapeutics, Autonomous Healthcare, Venova Technologies, Atantares. These companies were founded in 2020 or later.